Series: The French Healthcare System (2018) — Part 3/3
The collective psychological construct — perfect healthy bodies, confusion between care and superfluity — shapes our relationship to the healthcare system: the primacy of technology over economics. This progressivism, this refusal of death against which technological omnipotence is deployed, partly explains the galloping inflation of costs.
Gilead’s molecule revolutionised hepatitis C treatment — virus eradication in 99% of cases. But the cost is ~$75,000. The price is not conditioned by manufacturing cost but by health authority solvency — $300 in India, $75,000 in the USA.
Fourth age and dependency: Alzheimer’s will rise from 40 to 135 million cases between 2015 and 2050. Cancer prevalence up 70% in 20 years. Metabolic syndrome: 47% of US adults obese by 2030. Diabetes in France: €10B in 2014, 15% of national health insurance spending.
These socio-demographic shifts constitute major spending blocks whose weight will grow over the next 50 years. This is the analytical foundation of the PREDICARE programme.
Doctrinal notes and explorations on AI in regulated systems. Once or twice a month. One-click unsubscribe.